Copyright © 2007 by Academic Press. All rights of reproduction in any form reserved.
subjects to pregnant women fails to account for the impact of physiologic changes that occur during pregnancy. This disregard for the changes in maternal physiology may affect drug efficacy and ultimately may impact the overall pregnancy outcome.
These issues have begun to be addressed by the Food and Drug Administration, which has established a Pharmacokinetics in Pregnancy Working Group of the Pregnancy Labeling Task Force, associated with the Center for Drug Evaluation and Research.
Was this article helpful?